|
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
18/06/2021 |
CIM |
|
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
21/05/2021 |
CIM |
|
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
22/05/2021 |
CIM |
|
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
18/06/2021 |
CIM |
|
Itolizumab-Plasmapheresis in patients with COVID-19 |
30/06/2021 |
CIM |
|
VSSPs in renal carcinoma. |
21/06/2023 |
CIM |
|
Nimotuzumab in COVID-19 |
21/05/2021 |
CIM |
|
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT |
20/10/2021 |
CIM |
|
NeuroEPO in mild-moderate Alzheimer's disease |
20/09/2022 |
CIM |
|
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
22/09/2022 |
CIM |
|
Her1 vaccine in metastatic colon and prostate cancer |
16/08/2023 |
CIM |
|
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series |
2012-09-12 |
CIGB |
|
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection |
2012-10-12 |
CIGB |
|
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
2013-01-17 |
CIGB |
|
Safety with interferon in skin carcinomas (SCIENCE study) |
2013-01-30 |
CIGB |
|
Interferon Combination in basal cell carcinoma (InCarbacel-V study) |
2013-02-01 |
CIGB |
|
THERESA-4 Study |
2011-10-25 |
CIGB |
|
INJURE Study |
2011-07-11 |
CIGB |
|
Teravac HIV in chronic HIV-1. |
2011-08-10 |
CIGB |
|
SOFIA Study |
2011-05-24 |
CIGB |
